» Articles » PMID: 33613979

Silver Nanoparticles Achieve Cytotoxicity Against Breast Cancer by Regulating Long-chain Noncoding RNA XLOC_006390-mediated Pathway

Overview
Date 2021 Feb 22
PMID 33613979
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The specific cytotoxic effect of nanoparticles on tumor cells may be used in future antitumor clinical applications. Silver nanoparticles (AgNPs) have been reported to have potent cytotoxic effect, but the mechanism is unclear. Here, AgNPs were synthesized, and the particle average size was 63.1 ± 8.3 nm and showed a nearly circular shape, which were determined by transmission electron microscopy and field emission scanning electron microscopy. The selected area electron diffraction patterns showed that the nanoparticles were crystalline. The energy-dispersive X-ray spectrum proved that silver is the main component of nanoparticles. The AgNPs showed potent cytotoxicity in breast cancer cells, no matter whether they were tamoxifen sensitive or resistant. Next, we found that a long noncoding RNA, XLOC_006390, was decreased in AgNPs-treated breast cancer cells, coupled to inhibited cell proliferation, altered cell cycle and apoptotic phenotype. Downstream of AgNPs, XLOC_006390 was recognized to target miR-338-3p and modulate the SOX4 expression. This signaling pathway also mediates the AgNPs function of sensitizing tamoxifen-resistant breast cancer cells to tamoxifen. These results provide a new clue for the antitumor mechanism of AgNPs, and a new way for drug development by using AgNPs.

Citing Articles

Bioinspired multifunctional silver nanoparticles by Smilax Chenensis and their enhanced biomedical and catalytic applications.

Gaddam S, Kotakadi V, Allagadda R, T V, Velakanti S, Samanchi S Sci Rep. 2024; 14(1):29909.

PMID: 39622871 PMC: 11612181. DOI: 10.1038/s41598-024-77071-9.


Silver Nanoparticles in 3D Printing: A New Frontier in Wound Healing.

Astaneh M, Fereydouni N ACS Omega. 2024; 9(40):41107-41129.

PMID: 39398164 PMC: 11465465. DOI: 10.1021/acsomega.4c04961.


Antitumor efficacy of silver nanoparticles reduced with β-D-glucose as neoadjuvant therapy to prevent tumor relapse in a mouse model of breast cancer.

Franco Molina M, Reding Hernandez D, Garcia Coronado P, Kawas J, Zarate Trivino D, Hernandez Martinez S Front Pharmacol. 2024; 14:1332439.

PMID: 38333224 PMC: 10851876. DOI: 10.3389/fphar.2023.1332439.


Green Synthesis and Characterization of Silver Nanoparticles from Eclipta alba and Its Activity Against Triple-Negative Breast Cancer Cell Line (MDA-MB-231).

Mani S, Jayakumar P, Pavithra M, Saranya K, Rathinavel T, Ammashi S Mol Biotechnol. 2023; 66(12):3597-3607.

PMID: 37993758 DOI: 10.1007/s12033-023-00959-w.


Multiple RNA Profiling Reveal Epigenetic Toxicity Effects of Oxidative Stress by Graphene Oxide Silver Nanoparticles in-vitro.

Yuan Y, Zhang Y, Liu S, Reza A, Wang J, Li L Int J Nanomedicine. 2023; 18:2855-2871.

PMID: 37283715 PMC: 10239647. DOI: 10.2147/IJN.S373161.


References
1.
Wu G, Pan H, Leng R, Wang D, Li X, Li X . Emerging role of long noncoding RNAs in autoimmune diseases. Autoimmun Rev. 2015; 14(9):798-805. DOI: 10.1016/j.autrev.2015.05.004. View

2.
Li L, Li L, Zhou X, Yu Y, Li Z, Zuo D . Silver nanoparticles induce protective autophagy via Ca/CaMKKβ/AMPK/mTOR pathway in SH-SY5Y cells and rat brains. Nanotoxicology. 2019; 13(3):369-391. DOI: 10.1080/17435390.2018.1550226. View

3.
Luan X, Wang Y . LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p. J Gynecol Oncol. 2018; 29(6):e95. PMC: 6189437. DOI: 10.3802/jgo.2018.29.e95. View

4.
Moradi-Sardareh H, Basir H, Hassan Z, Davoudi M, Amidi F, Paknejad M . Toxicity of silver nanoparticles on different tissues of Balb/C mice. Life Sci. 2018; 211:81-90. DOI: 10.1016/j.lfs.2018.09.001. View

5.
Verkhovskii R, Kozlova A, Atkin V, Kamyshinsky R, Shulgina T, Nechaeva O . Physical properties and cytotoxicity of silver nanoparticles under different polymeric stabilizers. Heliyon. 2019; 5(3):e01305. PMC: 6475655. DOI: 10.1016/j.heliyon.2019.e01305. View